Everyday physical activity, even light movement, improves cognitive processing speed, equivalent to reversing four years of cognitive aging. This highlights the short-term brain benefits of staying active.
The MIND diet slows cognitive decline in older adults, with Black participants requiring stricter adherence for benefits. Racial and gender differences suggest broader social, lifestyle, and biological factors influence the diet's effectiveness.
Music therapy improves dementia care by reducing anxiety, agitation, and depression, enhancing mood, memory, and cognitive function. Familiar songs trigger emotional and physical responses, potentially strengthening neural connections and supporting overall wellbeing.
Researchers observed that amyloid-beta and tau proteins are associated with a transition from hyperactivity to slower brain activity, which aligns with declines in attention and memory, suggesting potential early indicators of Alzheimer’s disease progression.
APOE4 carriers had higher blood-brain barrier permeability, even without cognitive decline or amyloid beta buildup, suggesting early vascular changes that may be linked to Alzheimer’s risk and neurodegeneration.
A study found untreated hypertension increases Alzheimer's risk by 36% and non-Alzheimer's dementia risk by 69%. Treating hypertension lowers these risks, highlighting the importance of antihypertensive medication.
A recent study found that regular nut consumption was linked to a 12% lower risk of developing dementia in middle-aged and older adults, with the greatest benefit seen in those eating up to one handful of unsalted nuts daily.
Higher omega-3 intake in older adults is linked to improved cognitive function, with benefits most notable in those with higher education or a history of stroke. Results suggest omega-3 may help prevent cognitive decline.
A meta-analysis found a strong association between higher TyG index levels and increased risk of cognitive decline, particularly in younger adults, men, and Asian populations, suggesting its potential as a useful marker for cognitive health monitoring.
Researchers discovered that Alzheimer’s disease progresses in two phases: a slow, early phase with silent damage to specific brain cells, followed by a faster, symptomatic phase. These insights could lead to earlier detection and targeted treatments.
A new study has found that the gene therapy COG-201, delivered through a nasal spray, can improve memory and decrease anxiety in animal models, offering a new approach to treating neurological conditions.
Researchers have discovered that non-neuronal brain cells, oligodendrocytes, produce about 30% of amyloid plaques in Alzheimer’s disease. This challenges the neuron-focused understanding of plaque formation and could lead to new therapeutic strategies targeting oligodendrocytes to slow disease progression.
Lower caffeine consumption was linked to a higher risk of memory impairment and worse Alzheimer's disease biomarkers, suggesting caffeine might offer protective effects against cognitive decline. However, more research is needed to confirm any direct benefits.
Recent longitudinal research found that older adults with mild cognitive impairment who engaged more frequently in cognitively stimulating activities maintained better memory, working memory, and attention, suggesting such activities could help slow cognitive decline.
A meta-analysis of 35 studies with over 849,000 participants found that higher fish consumption is associated with a lower risk of cognitive decline, but the link to dementia and Alzheimer’s disease remains less conclusive and requires further research.